Author

Mark C Poznansky

Unknown affiliation - Cited by 10,002

Biography

Mark C Poznansky is working at Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, 149 13th Street, Charlestown, Massachusetts, 02129, United States of America. Mark C Poznansky is serving as an editorial member and reviewer of several international reputed journals. Mark C Poznansky has successfully completed his Administrative responsibilities.
Title
Cited by
Year
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
WF Garcia-Beltran, EC Lam, KS Denis, AD Nitido, ZH Garcia, BM Hauser, ...Cell 184 (9), 2372-2383. e9, 2021202
2021
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
WF Garcia-Beltran, KJS Denis, A Hoelzemer, EC Lam, AD Nitido, ...Cell 185 (3), 457-466. e4, 2022202
870
2022
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2, and Ad26. COV2. S COVID-19 vaccines
V Naranbhai, WF Garcia-Beltran, CC Chang, C Berrios Mairena, ...The Journal of infectious diseases 225 (7), 1141-1150, 2022202
105
2022
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (vol 184, pg 2372, 2021)
WF Garcia-Beltran, EC Lam, K St Denis, AD Nitido, ZH Garcia, BM Hauser, ...Cell 184 (9), 2523-2523, 2021202
38
2021
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes
A Zaitsev, M Chelushkin, D Dyikanov, I Cheremushkin, B Shpak, K Nomie, ...Cancer Cell 40 (8), 879-894. e16, 2022202
24
2022
Mathematical modeling to simulate the effect of adding radiation therapy to immunotherapy and application to hepatocellular carcinoma
W Sung, TS Hong, MC Poznansky, H Paganetti, C GrassbergerInternational Journal of Radiation Oncology* Biology* Physics 2 (4), 1055-1062, 2022202
11
2022
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo
JA Torchia, AH Tavares, LS Carstensen, DY Chen, J Huang, T Xiao, ...Science advances 8 (49), eabq652, 2022202
7
2022
Response to severe acute respiratory syndrome coronavirus 2 initial series and additional dose vaccine in patients with predominant antibody deficiency
S Barmettler, DV DiGiacomo, NJ Yang, T Lam, V Naranbhai, AS Dighe, ...The Journal of Allergy and Clinical Immunology: In Practice 10 (), 122 …, 2022202
6
2022
Fresh tissue multi-omics profiling reveals immune classification and suggests immunotherapy candidates for conventional chondrosarcoma
B Li, G Li, X Yan, D Zhu, PP Lin, Z Wang, H Qu, X He, Y Fu, X Zhu, P Lin, ...Clinical Cancer Research 27 (23), 543-558, 2021202
6
2021
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19
DJ Gregory, A Vannier, AH Duey, TJ Roady, RK Dzeng, MN Pavlovic, ...Virulence 13 (1), 890-902, 2022202
6
2022
Response to SARS-CoV-2 Initial Series and Additional Dose Vaccine in Patients with Predominant Antibody Deficiency.
S Barmettler, DV DiGiacomo, NJ Yang, T Lam, V Naranbhai, AS Dighe, ...The Journal of Allergy and Clinical immunology. In Practice, 2022202
4
2022
B cells support the repair of injured tissues by adopting MyD88‐dependent regulatory functions and phenotype
RF Sîrbulescu, A Mamidi, SYC Chan, G Jin, M Boukhali, D Sobell, I Ilieş, ...The FASEB Journal 35 (12), e22019, 2021202
4
2021
Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii
S Raju Paul, A Scholzen, G Mukhtar, S Wilkinson, P Hobson, RK Dzeng, ...Frontiers in Immunology 1, 886698, 2022202
3
2022
MIAAIM: Multi-omics image integration and tissue state mapping using topological data analysis and cobordism learning
JM Hess, I Ilieş, D Schapiro, JJ Iskra, WM Abdelmoula, MS Regan, ...bioRxiv, 2021.12. 20.472858, 2021202
3
2021
Differential SARS-CoV-2 antibody profiles after allergic reactions to mRNA COVID-19 vaccine
Differential SARS-CoV- antibody profiles after allergic reactions to mRNA COVID-19 vaccineJS Maron, M Conroy, V Naranbai, U Samarakoon, T Motazedi, JR Farmer, ...The Journal of Infectious Diseases, 0
2
2022
Whole Blood Interferon γ Release Is a More Sensitive Marker of Prior Exposure to Coxiella burnetii Than Are Antibody Responses
A Scholzen, M de Vries, HP Duerr, HJ Roest, AE Sluder, MC Poznansky, ...Frontiers in Immunology 1, 701811, 010
2
2021
Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity
AE Sluder, S Raju Paul, L Moise, C Dold, G Richard, L Silva-Reyes, ...Frontiers in immunology 3, 90372, 2022202
1
2022
Q fever vaccine development: Challenges and progress in balancing safety and efficacy
AE Sluder, MC PoznanskyCell Reports Medicine 2 (2), 20220
1
2021
Deep immune profiling of whole blood to identify early immune signatures that correlate to patient outcome after major trauma
AE Mendoza, SR Paul, M El Hechi, L Naar, C Nederpelt, S Mikdad, ...Journal of Trauma and Acute Care Surgery 90 (6), 959-966, 20220
1
2021